Document is current

Any future updates will be listed below

Erratum to: Assessing the safety and efficacy of ruxolitinib in a multicenter, open-label study in Japanese patients with myelofibrosis

Crossref DOI link: https://doi.org/10.1007/s12185-017-2196-2

Published Online: 2017-02-07

Published Print: 2017-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark